Veeva Systems (VEEV) Stock Forecast & Price Target

$260.77 -4.07 (-1.54%)

Closing price 03:59 PM Eastern

Extended Trading

$260.90 +0.13 (+0.05%)

As of 07:59 PM Eastern

Compare

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 28 Analyst Ratings

Sell
1

Hold
8

Buy
19

Based on 28 Wall Street analysts who have issued ratings for Veeva Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 28 analysts, 1 has given a sell rating, 8 have given a hold rating, and 19 have given a buy rating for VEEV.

Consensus Price Target

$284.88
9.25% Upside

According to the 28 analysts' twelve-month price targets for Veeva Systems, the average price target is $284.88. The highest price target for VEEV is $340.00, while the lowest price target for VEEV is $165.00. The average price target represents a forecasted upside of 9.25% from the current price of $260.77.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for VEEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Veeva Systems and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VEEV Analyst Ratings Over Time

Type	Current Forecast 9/9/25 to 9/9/26	1 Month Ago 8/10/25 to 8/10/26	3 Months Ago 6/11/25 to 6/11/26	1 Year Ago 9/9/24 to 9/9/25
Strong Buy	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	19 Buy rating(s)	18 Buy rating(s)	18 Buy rating(s)	17 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$284.88	$247.08	$250.96	$301.48
Forecasted Upside	9.25% Upside	5.47% Upside	55.35% Upside	6.71% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

VEEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

VEEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Veeva Systems Stock vs. The Competition

Type	Veeva Systems	Healthcare Companies	Broader Market
Consensus Rating Score	2.64	2.30	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	9.25% Upside	920.95% Upside	16.48% Upside
News Sentiment Rating	Positive News See Recent VEEV News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/8/2026	Wells Fargo & Company 3 of 5 stars	Stan Berenshteyn 2 of 5 stars	Reiterated Rating	Overweight	$330.00	+20.43%
8/28/2026	Citigroup 4 of 5 stars	Tyler Radke 1 of 5 stars	Boost Target	Neutral	$190.00 ➝ $273.00	-3.63%
8/27/2026	Piper Sandler 2 of 5 stars	Billy Fitzsimmons Not Rated	Boost Target	Overweight	$295.00 ➝ $320.00	+12.09%
8/27/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Grossman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$300.00	+3.88%
8/27/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$270.00 ➝ $310.00	+26.68%
8/27/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$295.00	+20.55%
8/27/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Valiquette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$270.00 ➝ $280.00	-1.12%
8/27/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Vruwink Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$260.00 ➝ $300.00	+5.23%
8/27/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Dodge Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Market Perform	$175.00 ➝ $270.00	-5.29%
8/27/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$220.00 ➝ $260.00	-9.29%
Get the Latest News and Ratings for VEEV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Veeva Systems and its competitors with MarketBeat's FREE daily newsletter.
8/27/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$275.00 ➝ $315.00	+11.03%
8/27/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$190.00 ➝ $290.00	+0.50%
8/27/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$275.00 ➝ $325.00	+12.29%
8/27/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tamjid Chowdhury Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$276.00 ➝ $310.00	+6.38%
8/27/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Hettenbach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$215.00 ➝ $275.00	-2.12%
8/27/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$262.00 ➝ $305.00	+24.63%
8/24/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Rhyee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$235.00 ➝ $283.00	+13.81%
8/17/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Wong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$225.00 ➝ $300.00	+24.78%
8/12/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C-) ➝ Hold (C)
6/4/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$285.00	+59.54%
6/4/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$185.00	+3.53%
6/4/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$225.00	+25.92%
6/4/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriela Borges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sell	$190.00 ➝ $165.00	-7.23%
6/4/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$340.00	+90.27%
5/14/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
3/10/2026	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
2/20/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexei Gogolev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$330.00 ➝ $296.00	+63.66%
12/12/2025	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Schoenhaus Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Sector Weight
3/6/2025	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Sector Perform	$240.00 ➝ $245.00	+3.61%
3/6/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Garro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$280.00 ➝ $280.00	+19.63%
12/6/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$280.00 ➝ $290.00	+13.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:55 PM ET.

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 7, 2026. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

Veeva Systems
Bull Case

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

Veeva Systems Inc. recently raised its fiscal 2027 outlook, signaling strong operating momentum driven by Vault CRM migrations, increased research-and-development investment, and the adoption of Falcon AI, which supports continued revenue growth and expanding profitability.
The company demonstrated strong financial performance in its latest quarter, reporting revenue of approximately $928 million, which represents a 17.6% year-over-year increase, while adjusted earnings exceeded analyst expectations, highlighting the effectiveness of its recurring-revenue model.
Major pharmaceutical clients such as Regeneron and Biogen have adopted Veeva’s AI-powered Vault CRM suite globally, and the introduction of Falcon Safety, an agentic AI product for biopharmaceutical safety operations, deepens customer relationships and expands the company's role in critical commercial and safety workflows.
With the stock currently trading at $274.02, Veeva Systems Inc. offers a compelling valuation for long-term growth investors, supported by a consensus rating of "Moderate Buy" and an average price target of $284.46, suggesting potential for further upside as the company executes on its AI expansion strategy.
Notable investor Michael Burry has remained bullish on Veeva Systems Inc., citing its strong fundamentals and attractive valuation compared to peers, which adds a layer of confidence for investors seeking high-quality software stocks in the healthcare technology sector.

Veeva Systems
Bear Case

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

Recent insider selling activity may weigh on investor sentiment, as Veeva’s exiting president sold 10,000 shares for approximately $2.8 million, representing about 51% of the executive’s direct equity stake, which can raise caution after the stock’s strong advance.
Analysts and portfolio commentary warn that market saturation could limit future growth, as the company faces a challenging environment where continued execution and strong guidance upgrades are required to justify its premium earnings multiple following a substantial rally.
The stock is trading at a premium earnings multiple, with a P/E ratio of 44.44, which may be difficult to sustain if the company fails to maintain its high growth rates or if competition intensifies in the cloud software space for the life sciences industry.
Despite strong recent performance, the company faces the risk of slowing growth as it matures, with some analysts suggesting that the current valuation leaves little room for error in execution, particularly as the company transitions from a high-growth phase to a more established market position.

VEEV Forecast - Frequently Asked Questions

According to the research reports of 28 Wall Street equities research analysts, the average twelve-month stock price forecast for Veeva Systems is $284.88, with a high forecast of $340.00 and a low forecast of $165.00.

28 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last year. There is currently 1 sell rating, 8 hold ratings and 19 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" VEEV shares.

According to analysts, Veeva Systems's stock has a predicted upside of 9.25% based on their 12-month stock forecasts.

Over the previous 90 days, Veeva Systems's stock had 3 upgrades and 1 downgrade by analysts.

Veeva Systems has been rated by research analysts at Barclays, BMO Capital Markets, Canaccord Genuity Group, Citigroup, Guggenheim, Jefferies Financial Group, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer, Piper Sandler, Robert W. Baird, Royal Bank Of Canada, Stifel Nicolaus, TD Cowen, Truist Financial, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Veeva Systems more than other "healthcare" companies. The consensus rating for Veeva Systems is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how VEEV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Veeva Systems Recommendations

MarketBeat monitors more than a dozen sources for Veeva Systems analyst ratings, with the most recent rating issued on 9/8/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

VEEV Analyst Ratings Over Time

VEEV Analyst Recommendations By Month

VEEV Price Targets by Month

Veeva Systems Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

Veeva Systems
Bull Case

Veeva Systems
Bear Case

VEEV Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Veeva Systems Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

VEEV Analyst Ratings Over Time

VEEV Analyst Recommendations By Month

VEEV Price Targets by Month

Veeva Systems Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

Veeva Systems Bull Case

Veeva Systems Bear Case

VEEV Forecast - Frequently Asked Questions

What is Veeva Systems' forecast for 2026?

Should I buy or sell Veeva Systems stock right now?

Does Veeva Systems's stock price have much upside?

Has Veeva Systems been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Veeva Systems?

Do Wall Street analysts like Veeva Systems more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Veeva Systems Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Veeva Systems
Bull Case

Veeva Systems
Bear Case